Literature DB >> 194843

Preferential enhancement of IgE antibody formation by Bordetella pertussis.

M Suko, T Ogita, H Okudaira, Y Horiuchi.   

Abstract

Preferential enhancement of IgE antibody response was observed in BALF/c mice by the administration of Bordetella pertussis with antigen (DNP-Salmonella). Correlation between B cell mitogenic activity and adjuvant action among B. pertussis, Salmonella, lipopolysaccharide of Escherichia coli and Ficoll was examined but was not found. Thymus-derived cells seemed necessary to develop adjuvant action of B. pertussis since antibody response in athymic nude mice was not influenced by B. pertussis. Helper function of adoptively transfered spleen cells was enhanced by immunization of the donor mice with carrier antigen in the presence of B. pertussis. The magnitude of enhancement was greatest in IgE class. The results indicated that preferential enhancement of IgE antibody formation by B. pertussis is mediated by the augmentation of carrier-specific helper function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194843     DOI: 10.1159/000231845

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Immune suppression and induction of gamma interferon by pertussis toxin.

Authors:  F R Vogel; T W Klein; W E Stewart; T Igarashi; H Friedman
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

Review 2.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine.

Authors:  R S Speirs; R W Benson; D W Roberts
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

4.  Does pertussis infection induce manifestation of allergy?

Authors:  A Schuster; A Hofmann; D Reinhardt
Journal:  Clin Investig       Date:  1993-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.